ID

12953

Beskrivning

Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01467323

Länk

https://clinicaltrials.gov/show/NCT01467323

Nyckelord

  1. 2016-01-07 2016-01-07 -
Rättsinnehavare

CC BY-NC 3.0

Uppladdad den

7 januari 2016

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0

Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Diabetes NCT01467323

Eligibility Diabetes NCT01467323

  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01467323
Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
subjects with insulin requiring type 1 or type 2 diabetes for at least 24 months
Beskrivning

insulin requiring type 1 or type 2 diabetes

Datatyp

boolean

Alias
UMLS CUI [1]
C0011849
current treatment with human insulin (either premix of short and long/intermediate acting insulin) in a twice daily treatment regimen preparation and/or self-mix for at least 12 months
Beskrivning

insulin

Datatyp

boolean

Alias
UMLS CUI [1]
C0021641
body mass index (bmi) below or equal to 35.0 kg/m^2
Beskrivning

body mass index

Datatyp

boolean

Alias
UMLS CUI [1]
C1305855
hba1c below or equal to 11.0%
Beskrivning

hba1c

Datatyp

boolean

Alias
UMLS CUI [1]
C0019018
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
total daily insulin dose at least 1.4 iu/kg
Beskrivning

total daily insulin dose at least 1.4 iu/kg

Datatyp

boolean

Alias
UMLS CUI [1]
C0021641
treatment with oral hypoglycaemic agents within the month prior to inclusion
Beskrivning

oral hypoglycaemic agents

Datatyp

boolean

Alias
UMLS CUI [1]
C0359086
recurrent severe hypoglycaemia (as judged by the investigator)
Beskrivning

hypoglycemia

Datatyp

boolean

Alias
UMLS CUI [1]
C0020615
active proliferative retinopathy
Beskrivning

proliferative retinopathy

Datatyp

boolean

Alias
UMLS CUI [1]
C0339467
impaired renal function with creatinine at least 150 mcmol/l (1.7 mg/dl)
Beskrivning

impaired renal function with creatinine at least 150 mcmol/l (1.7 mg/dl)

Datatyp

boolean

Alias
UMLS CUI [1]
C0201976
history of pancreatitis
Beskrivning

pancreatitis

Datatyp

boolean

Alias
UMLS CUI [1]
C0030305

Similar models

Eligibility Diabetes NCT01467323

  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01467323
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
insulin requiring type 1 or type 2 diabetes
Item
subjects with insulin requiring type 1 or type 2 diabetes for at least 24 months
boolean
C0011849 (UMLS CUI [1])
insulin
Item
current treatment with human insulin (either premix of short and long/intermediate acting insulin) in a twice daily treatment regimen preparation and/or self-mix for at least 12 months
boolean
C0021641 (UMLS CUI [1])
body mass index
Item
body mass index (bmi) below or equal to 35.0 kg/m^2
boolean
C1305855 (UMLS CUI [1])
hba1c
Item
hba1c below or equal to 11.0%
boolean
C0019018 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
total daily insulin dose at least 1.4 iu/kg
Item
total daily insulin dose at least 1.4 iu/kg
boolean
C0021641 (UMLS CUI [1])
oral hypoglycaemic agents
Item
treatment with oral hypoglycaemic agents within the month prior to inclusion
boolean
C0359086 (UMLS CUI [1])
hypoglycemia
Item
recurrent severe hypoglycaemia (as judged by the investigator)
boolean
C0020615 (UMLS CUI [1])
proliferative retinopathy
Item
active proliferative retinopathy
boolean
C0339467 (UMLS CUI [1])
impaired renal function with creatinine at least 150 mcmol/l (1.7 mg/dl)
Item
impaired renal function with creatinine at least 150 mcmol/l (1.7 mg/dl)
boolean
C0201976 (UMLS CUI [1])
pancreatitis
Item
history of pancreatitis
boolean
C0030305 (UMLS CUI [1])

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial